Dimethyl fumarate attenuates liver injury in a mouse model of cecal ligation and puncture by modulating inflammatory, angiogenic and pyroptotic pathways
Open Access
- 17 July 2025
- journal article
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 26 (1) , 134
Abstract
Sepsis is a prevalent ailment that significantly affects hospitalized individuals around the globe. It is characterized by uncontrolled inflammatory responses resulting in organ injury and leading to high morbidity and mortality. The liver, a vital organ, is affected by sepsis, resulting in liver dysfunction. Dimethyl fumarate (DMF), which is approved for the treatment of multiple sclerosis, has anti-inflammatory and neuroprotective properties through the inhibition of multiple inflammatory mediators. Hence, the present study aimed to assess the hepatoprotective potential of DMF against sepsis. Four groups of mice (6 animals per group) were divided into a sham group, which was subjected to only anaesthesia and a midline abdominal incision; the cecal ligation and puncture (CLP) group was anaesthetized and underwent an abdominal incision followed by the ligation of the cecum under the ileocecal valve and perforation twice with a needle; the vehicle group was given a solvent of DMF 1 h before the CLP, and the CLP group received 50 mg/kg of DMF via intraperitoneal (ip) injection 1 h before CLP. Following the procedure (24 h post-CLP), the mice were given unrestricted access to food and drink throughout the day. Serum was used to measure the levels of angiopoietin 2, AST and ALT. Enzyme-linked immunosorbent assay (ELISA) was used to investigate the levels of TNF-α, IL-6, MIF, ICAM-1, F2-isoprostanes, VEGF, and caspase 11 in liver tissues. To evaluate the degree of liver damage, a biopsy of the liver was performed. The results revealed that mice exposed to CLP had high levels of AST and ALT in comparison with sham mice. Furthermore, levels of TNF-α, IL-6, MIF, ICAM-1, F2-isoprostanes, VEGF, and caspase 11 in liver tissues were also notably elevated as compared with sham mice. The levels of these parameters were significantly decreased in septic mice pre-treated with DMF. Mice with CLP showed a severe degree of liver damage as compared with sham mice. DMF pre-treatment mitigated liver injury. This study suggests that DMF has hepatoprotective effects on septic mice via the modulation of inflammation, adhesion molecules, angiopoietin 2 and pyroptosis.Keywords
This publication has 96 references indexed in Scilit:
- OPTIMIZING DOSAGE OF KETAMINE AND XYLAZINE IN MURINE ECHOCARDIOGRAPHYClinical and Experimental Pharmacology and Physiology, 2007
- Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortalityJournal of Experimental Medicine, 2006
- A review on pro- and anti-angiogenic factors as targets of clinical interventionPharmacological Research, 2006
- VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED DURING THE FIRST 48 HOURS OF HUMAN SEPTIC SHOCK AND CORRELATES WITH VASCULAR PERMEABILITYShock, 2005
- Endotoxin-Induced Myocardial DysfunctionCirculation Research, 2005
- PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEVERE SEPSISShock, 2005
- MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSISShock, 2004
- Macrophage migration inhibitory factor (MIF): mechanisms of action and role in diseaseMicrobes and Infection, 2002
- Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in SepsisJournal of Experimental Medicine, 1999
- Plasma Levels of Cytokines in Primary Septic Shock in Humans: Correlation with Disease SeverityThe Journal of Infectious Diseases, 1995